Regeneron Pharmaceuticals Stock Price - REGN

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
CHART Trader
Monthly Subscription
for only
$30.66
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
After Hours
Last Trade
Last $ 300.19 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -1.38 -0.46% 300.19 303.51 298.70 303.51 301.57 19:59:44
Bid Price Ask Price Spread Spread % News
295.00 315.66 20.66 6.55% - 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
9,091 530,047 $ 301.45 $ 159,783,797 715,796 271.37 - 445.00
Last Trade Time Type Quantity Stock Price Currency
16:47:46 formt 243 $ 300.19 USD

Regeneron Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 32.97B 109.83M $ 2.44B 21.30 15.20 108.67M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 1.10%

more financials information »

Regeneron Pharmaceuticals News

Loading Messages....

Latest REGN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical REGN Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week300.11310.15298301.8395825k0.080.03%
1 Month288.75310.15271.37290.7904753k11.443.96%
3 Months304.35315.3801271.37292.8251677k-4.16-1.37%
6 Months346.4351.9271.37305.0193762k-46.21-13.34%
1 Year399.9445271.37344.0035747k-99.71-24.93%
3 Years366.42543.5518271.37374.7508810k-66.23-18.07%
5 Years367.79605.9299271.37401.7610794k-67.6-18.38%

Regeneron Pharmaceuticals Description

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis and asthma; Libtayo in cutaneous squamous cell carcinoma; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.